Invent here, manufacture there.
For decades, it’s been the strategy of many American manufacturing firms. But today, as many firms invest in overseas R&D, they’ve taken the trend a step further: “Invent there, manufacture there.” This strategy poses a serious challenge to national prosperity and security.
This year, MForesight: Alliance for...
2017 was a stellar first year for the RAPID Manufacturing Institute. Fifty-six members joined the RAPID community—coming from industry, academia, government labs and other nonprofits. RAPID’s 2017 Annual Report, “Working Together to Grow Stronger” reflects the Institute’s efforts to create effective collaborations that result in breakthrough...
Accelerating energy innovation by manufacturers in America would boost economic growth and global competitiveness, while addressing key national security and environmental goals. But market failures lead to gaps in the private sector’s response to this imperative. That’s where the Department of Energy’s Manufacturing USA innovation institutes come...
The biopharmaceutical industry makes a substantial impact on the health, well-being, and economic prosperity of the nation. The industry develops and manufactures life-changing therapies for patients and contributes significantly to the U.S. economy. Currently, the industry accounts for nearly $800B of total economic activity per year and directly...
The 2018 Strategic Investment Plan (SIP) and Technology Roadmap describes DMDII’s directional priorities for 2018 and beyond. A vision of making “every part better than the last” is introduced as a means for focusing the Institute’s efforts, building on past research, and reducing technology to practice. The vision describes a future state where...
